AGBL2 and heart failure: In addition, 68 participants positive for RF-IgA, RF-IgM or anti-CCP2 antibodies experienced heart failure although there was not significant association of RF-IgA, RF-IgM, or anti-CCP2 antibodies with incident heart failure in our longitudinal analysis.